Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases

British Journal of Surgery

Volumn 90, Issue 5, 2003, Pages 567-574

  Elias, D ^a   Ouellet, J F ^a   Bellon, N ^a   Pignon, J P ^a   Pocard, M ^a   Lasser, P ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COLORECTAL CANCER; FEMALE; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROGNOSIS; SURGICAL MORTALITY; SURVIVAL RATE; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; COLONOSCOPY; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0038630852     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4071     Document Type: Article

References (34)

1. Hughes KS, Simon R, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 1986; 100: 278-284.
2. Norlinger B, Jaeck D, Guignet M, Vaillant JC, Balladur P, Schaal JC et al. Résection Chirurgicale des Métastases Hépatiques, Enquête de l'Association Française de Chirurgie. Springer: Paris, 1992; 141-175.
3. Eckberg H, Tranberg KG, Andersson R, Lundstedt C, Hagerstrand I, Ranstam J et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg 1986; 73: 727-731.
4. Cady B, McDermott WV. Major hepatic resection for metachronous metastases from colon cancer. Ann Surg 1985; 210: 204-209.
5. Foster JH. Survival after liver resection for secondary tumors. Am J Surg 1978; 135: 389-394.
6. Adson MA. The resection of hepatic metastases. Another view. Arch Surg 1989; 124: 1023-1024.
7. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-321.
8. Jamison RL, Donohue JH, Nagorney DM, Rosen CB, Harmsen WS, Ilstrup DM. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 1997; 132: 505-511.
9. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71.
10. Iwatsuki S, Dvorchik I, Madariaga JR, Marsh JW, Dodson F, Bonham AC et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 1999; 189: 291-299.
11. Pedersen IK, Burcharth F, Roikjaer O, Baden H. Resection of liver metastases from colorectal cancer. Indications and results. Dis Colon Rectum 1994; 37: 1078-1082.
12. Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000; 231: 487-499.
13. Fidler IJ. Seed and soil revisited: contribution of the organ microenvironment to cancer metastasis. Surg Oncol Clin North Am 2001; 10: 257-269.
14. Elias D, Detroz B, Lasser P, Plaud B, Jerbi G. Is simultaneous hepatectomy and intestinal anastomosis safe? Am J Surg 1995; 169: 254-260.
15. Elias D, Lasser P, Debaene B, Doidy L, Billard V, Spencer A et al. Intermittent vascular exclusion of the liver (without vena cava clamping) during major hepatectomy. Br J Surg 1995; 82: 1535-1539.
16. Takayama T, Makuuchi M, Kubota K, Harihara Y, Hui AM, Sano K et al. Randomized comparison of ultrasonic vs. clamp transection of the liver. Arch Surg 2001; 136: 922-928.
17. Elias DM, Ouellet JF. Intraperitoneal chemohyperthermia: rationale, technique, indications, and results. Surg Oncol Clin North Am 2001; 10: 915-933.
18. Elias D, Blot F, El Otmany A, Antoun S, Lasser P, Boige V et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001; 92: 71-76.
19. Schemper M, Smith TL. A note on quantifying follow-up in study of failure time. Control Clin Trials 1996; 17: 343-346.
20. Tsavellas G, Patel H, Allen-Mersh TG. Detection and clinical significance of occult tumour cells in colorectal cancer. Br J Surg 2001; 88: 1307-1320.
21. Sadahiro S, Suzuki T, Tokunaga N, Yurimoto S, Yasuda S, Tajima T et al. Detection of tumor cells in the portal and peripheral blood of patients with colorectal carcinoma using competitive reverse transcriprase-polymerase chain reaction. Cancer 2001; 92: 1251-1258.
22. Hansen E, Wolff N, Knuechel R, Ruschoff J, Hofstaedter F, Taeger K. Tumor cells in blood shed from the surgical field. Arch Surg 1995; 130: 387-393.
23. Oefelein MG, Kaul K, Herz B, Blum MD, Holland JM, Keeler TC et al. Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. J Urol 1996; 155: 238-242.
24. Pollock RE, Roth JA. Cancer-induced immunosuppression: implications for therapy? Semin Surg Oncol 1989; 5: 414-419.
25. Kavanaugh DY, Carbone DP. Immunologic dysfunction in cancer. Hematol Oncol Clin North Am 1996; 10: 927-951.
26. Deppe G. Chemotherapy of Gynecologic Cancer (2nd edn). John Wiley & Sons, Inc.: New York, 1990.
27. Rougier P, Van Cutsem E, Bajetta E, Nierderle N, Possinger K, Labianca R et al. Randomized trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 1998; 352: 1407-1412.
28. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000; 355: 1041-1047.
29. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995; 221: 124-132.
30. Adson MA. Resection of liver metastases: when is it worthwhile? World J Surg 1987; 11: 511-520.
31. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Colt DG et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15: 938-946.
32. Elias D, Ouellet JF. Incidence, distribution and significance of hepatic hilar lymph node metastases. Surg Oncol Clin North Am 2003; (in press).
33. Weber SM, Janargin WR, DeMatteo RP, Blumgart LH, Fong Y. Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 2000; 7: 643-650.
34. Elias D, Cavalcanti A, Sabourin JC, Pignon JP, Ducreux M, Lasser P et al. Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases. J Surg Oncol 1998; 69: 88-93.